FDA approves cryogenic ablation for menorrhagia
This article was originally published in Clinica
Executive Summary
The US FDA has approved for sale what is claimed to be the first cryosurgical system for endometrial ablation. The Her Option Uterine cryoablation Therapy system, developed by CryoGen, was cleared via the agency's PMA process as a treatment for menorrhagia due to benign causes in pre-menopausal women.